KRAS and pancreatic neoplasm: miR-206 functions as a tumor suppressor in pancreatic cancer by inhibiting metastatic cell invasion and overall tumor growth and proliferation through the targeting of oncogenic K-Ras, an initiator of PDAC and of ANXA2, a regulator of extra cellular matrix degradation [74].